| Dr Scott Sadamu Morioka, MD | |
|
321 N Kuakini St Ste 501, Honolulu, HI 96817-2387 | |
| (808) 762-0777 | |
| (808) 762-0775 |
| Full Name | Dr Scott Sadamu Morioka |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 22 Years |
| Location | 321 N Kuakini St Ste 501, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306051834 | NPI | - | NPPES |
| 598386 | Medicaid | HI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kuakini Medical Center | Honolulu, HI | Hospital |
| The Queens Medical Center | Honolulu, HI | Hospital |
| Pali Momi Medical Center | Aiea, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hawaii Injury Recovery Center, Inc. | 4880012541 | 2 |
News Archive
A new study published in the British Medical Journal December 2019 suggests a novel risk factor for heart disease – the season in which the individual is born. The large study carried out in the US shows that people born in either spring or summer had a significant, though slight, increase in the risk of fatal heart disease, when compared to the autumn-born. Why this should be so is unknown as of now.
"Progress in ensuring that women in poor countries have access to modern methods of contraception has stalled," according to a new report by the United Nations Population Fund and the Guttmacher Institute, BMJ reports.
Significant out-of-pocket costs that cancer patients can face before Medicare insurance drug benefits kick in may delay the patients' treatment with a novel class of targeted therapies, according to a University of North Carolina Lineberger Comprehensive Cancer Center-led study.
The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
› Verified 5 days ago
| Entity Name | Hawaii Injury Recovery Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881203289 PECOS PAC ID: 4880012541 Enrollment ID: O20200911000757 |
News Archive
A new study published in the British Medical Journal December 2019 suggests a novel risk factor for heart disease – the season in which the individual is born. The large study carried out in the US shows that people born in either spring or summer had a significant, though slight, increase in the risk of fatal heart disease, when compared to the autumn-born. Why this should be so is unknown as of now.
"Progress in ensuring that women in poor countries have access to modern methods of contraception has stalled," according to a new report by the United Nations Population Fund and the Guttmacher Institute, BMJ reports.
Significant out-of-pocket costs that cancer patients can face before Medicare insurance drug benefits kick in may delay the patients' treatment with a novel class of targeted therapies, according to a University of North Carolina Lineberger Comprehensive Cancer Center-led study.
The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Sadamu Morioka, MD 321 N Kuakini St Ste 501, Honolulu, HI 96817-2387 Ph: (808) 762-0777 | Dr Scott Sadamu Morioka, MD 321 N Kuakini St Ste 501, Honolulu, HI 96817-2387 Ph: (808) 762-0777 |
News Archive
A new study published in the British Medical Journal December 2019 suggests a novel risk factor for heart disease – the season in which the individual is born. The large study carried out in the US shows that people born in either spring or summer had a significant, though slight, increase in the risk of fatal heart disease, when compared to the autumn-born. Why this should be so is unknown as of now.
"Progress in ensuring that women in poor countries have access to modern methods of contraception has stalled," according to a new report by the United Nations Population Fund and the Guttmacher Institute, BMJ reports.
Significant out-of-pocket costs that cancer patients can face before Medicare insurance drug benefits kick in may delay the patients' treatment with a novel class of targeted therapies, according to a University of North Carolina Lineberger Comprehensive Cancer Center-led study.
The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
› Verified 5 days ago
Dr. Damien Kekaneinoa Tavares Iii, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2226 Liliha Street, Suite 407, Honolulu, HI 96817 Phone: 808-445-9172 Fax: 808-445-9182 |